Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia
Status:
Terminated
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and tolerability of ziprasidone during
long-term open-label administration in adolescents (ages 13-17) with schizophrenia.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.